At 9.41x EV/EBITDA versus BUD at 9.74x and Diageo at 11.45x, STZ trades roughly in line with or below the beer peer despite operating margins around 31% versus Diageo's 11.6% net margin, which suggests the discount may be a judgment call on revenue durability rather than a valuation anomaly. The 2.43x price-to-book versus BUD's 1.54x looks contradictory against STZ's 6.4% ROE versus BUD's 16.8%, though this appears partly an artifact of the goodwill drawdown from $8.0B to $5.3B that shrank the equity base and mechanically lifted book multiples. The 11.04x price-to-FCF multiple warrants particular caution given that trailing free cash flow has fallen to roughly $360M from about $1.85B; if cash generation does not recover, the true multiple on distributable earnings appears higher than the headline suggests, while the 3.5% dividend yield provides a floor that peers like SAM cannot match.

Gross margin's narrow 49.6%-54.3% range over ten quarters suggests the premium beer pricing power is intact, so the ~460 basis points of year-over-year operating margin compression appears driven below the gross line, with SG&A rising to 20.7% of revenue from 17.4% a year earlier — a shift that warrants investigation into whether it represents permanent spend or divestiture-related dis-synergies. Net margin is analytically unusable here, having swung from -41.1% to 32.9% over five quarters with only modest revenue differences, which implies the earnings line is being driven by equity-method and fair-value items rather than trading performance. On a normalized view, operating margin of 30-31% versus the mid-30s historically appears to be the metric closest to true earning power, and its stabilization or further erosion in coming quarters will likely determine whether the 9.88x forward P/E is a bargain or a value trap.

ROE of 6.4% versus ROIC of 4.3% indicates the gap between the two is being supplied by financial leverage and a shrunken equity base rather than operating strength, so the apparent equity return should not be read as evidence of superior asset productivity. With asset turnover trapped in the 0.09-0.12 range and capital expenditure running roughly two times depreciation at $177-$375M per quarter, the capital deployed in the Nava and Obregon expansions appears not yet reflected in incremental revenue, which would keep ROIC depressed until brewery utilization normalizes. If ROIC continues to print in the low single digits versus an estimated 8-10% weighted average cost of capital for a leveraged, cyclical consumer name, the risk is that the ongoing capex program destroys value on incremental investment; investors should monitor beer depletion growth against reported asset growth to test this hypothesis.

D/EBITDA in the 11-13x range for most quarters appears high for a beer producer, though it should be interpreted against depressed trailing EBITDA from the wine portfolio wind-down rather than as a pure capital-structure signal, and coverage of 5-10x suggests debt service was still serviceable on operating income. The negative interest coverage readings in 2025Q2 and 2025Q4 appear tied to the same non-operating losses that distorted net margin, so they should be read as accounting noise rather than a covenant event, but the 2026Q4 trough of 5.24x does show how thin the cushion became before the recent balance sheet change. The reported collapse in total debt to $116.5M in 2027Q2 alongside only a $400M decline in total liabilities is difficult to reconcile without further disclosure and warrants scrutiny; if genuine, the leverage risk recedes substantially, though the free cash flow issue would remain.

The persistent gap between the current ratio near 1.0 and a quick ratio around 0.5 indicates a business whose near-term liquidity is heavily anchored in inventory, and days inventory outstanding of 105-160 days versus days payable outstanding of 71-90 days suggests the company effectively funds its payables cycle with slow-moving beer and wine stock — an arrangement that looks comfortable in normal trading but sensitive to demand softening or input cost spikes. Working capital efficiency has nonetheless improved materially, with the cash conversion cycle compressing from roughly 110 days in 2025Q3 to 55 days in 2027Q2, which represents a genuine and favorable shift in how quickly value is turned into cash. Under a stress scenario of sustained negative free cash flow, current-ratio liquidity alone appears insufficient to cover both capex and dividends, so investors should treat the company's access to committed credit facilities as the relevant buffer — data not disclosed in the figures provided.